Purchase Order 36C24925P0515

Award Date 5/1/25
Potential Completion Date 5/15/25
Potential Value $14K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 to Mckesson Corporation, doing business as Mckesson, for the pharmaceutical product LEUKERAN. The contract has a ceiling value of $14,439.25 and a completion date of April 18, 2025. No set-aside designation was used for this award. Mckesson Corporation is a healthcare services and information technology company that provides pharmaceuticals, medical supplies,...
This is a $57,757 firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 to Mckesson Corporation, a for-profit healthcare services and IT company, for the pharmaceutical product LEUKERAN. The award does not utilize any set-aside designations. According to the information provided, Mckesson has a history of serving as a prime contractor for federal healthcare agencies, delivering a range of pharmaceutical products and services...
This firm fixed-price purchase order was awarded to Mckesson Corporation, a healthcare services and information technology company, by the Department of Veterans Affairs' Veterans Integrated Service Network 9 for the delivery of the pharmaceutical drug LEUKERAN (chlorambucil) 2mg. The contract has a ceiling value of $13,884.00 and an ultimate completion date of August 3, 2024. No set-aside designation was used. Mckesson has previously provided a variety of pharmaceutical products and services to...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 to Mckesson Corporation, a prominent healthcare services and IT company, for the pharmaceutical product LEUKERAN 2MG NDC: 80725-0610-25. The award, valued at $14,439.25, has an ultimate completion date of August 4, 2025. The contract is not set aside for any specific business category. Mckesson Corporation has a strong presence in federal healthcare contracting,...
The Department of Veterans Affairs awarded a firm fixed price purchase order to Mckesson Corporation, valued at $13,884.00, for the emergency procurement of LEUKERAN 2MG pharmaceuticals. This order does not have a set-aside designation and is expected to be completed by June 18, 2024. Mckesson Corporation is a healthcare services and IT company that has provided various pharmaceutical products and services to federal agencies, including the Department of Justice's Bureau of Prisons, the...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to Mckesson Corporation, a healthcare services and information technology company, for the delivery of LEUKERAN (chlorambucil) 2mg tablets. The contract has a ceiling value of $13,884 and a completion date of November 28, 2024. Mckesson, the prime contractor, has previously held numerous delivery orders and blanket purchase agreements with federal agencies...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 19 to the prime contractor, Mckesson Corporation, for the supply of 25-tablet bottles of the drug Leukeran (chlorambucil) with a ceiling value of $13,884.00. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 2, 2024. No set-aside designation was used. Mckesson Corporation is a healthcare services and information technology...
This firm fixed price purchase order contract was awarded by the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 to Mckesson Corporation, doing business as Mckesson, to provide LEUKERAN (CHLORAMBUCIL) 2MG TAB BOTTLE. The contract has a ceiling value of $28,928.50 and a completion date of January 8, 2025. Mckesson is a healthcare services and information technology company that has provided pharmaceutical products and services to various federal agencies, including the...
The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order to Mckesson Corporation, a healthcare services and information technology company, for the delivery of LEUKERAN 2MG 25 TABLET/BOTTLE X4 pharmaceutical products. The contract has a ceiling value of $55,536.00 and a completion date of December 31, 2024. Mckesson has provided a range of pharmaceutical products and services to various federal agencies, including the VA, Department of Health and Human Services' Indian...
The Department of Veterans Affairs, through the Veterans Integrated Service Network 19, awarded a firm fixed price purchase order to Mckesson Corporation, a healthcare services and information technology company, for the provision of LEUKERAN (CHLORAMBUCIL) 2MG TAB BOTTLE (2 BOTTLES). The contract has a ceiling value of $28,928.50 and an ultimate completion date of February 21, 2025. This award does not have a set-aside designation. Mckesson Corporation is the prime contractor and no...

This is a federal contract award from the Veterans Integrated Service Network 9 (VISN 9), a civilian agency, to the prime contractor Mckesson Corporation for the pharmaceutical product LEUKERAN. The contract is a firm fixed-price purchase order with a ceiling value of $14,439.25 and an ultimate completion date of May 15, 2025. The contract does not have a set-aside designation. Mckesson Corporation is a prominent healthcare services and information technology company that provides pharmaceutical, medical supply, and healthcare solutions to various federal government agencies, including the Department of Justice's Bureau of Prisons, Department of Veterans Affairs, and Department of Health and Human Services. This contract award supports the provision of pharmaceutical products to federal healthcare programs and facilities served by VISN 9.

Generated 5/2/25, 9:44 AM